January 27, 2015
Gilead Sciences to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 3, 2015
Conference Call and Webcast to Follow
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 27, 2015--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth
quarter and full year 2014 financial results will be released on
Tuesday, February 3, at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern
Time, Gilead’s management will host a conference call to discuss the
company’s financial results for the fourth quarter and full year 2014 as
well as provide a general business update and financial guidance for
The live webcast of the call can be accessed at the company’s Investors
page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-877-359-9508 (U.S.) or 1-224-357-2393 (international) and dial the
participant passcode 56363760 to access the call. Telephone replay will
be available approximately two hours after the call through 11:59 p.m.
Eastern Time, February 5, 2015. To access the replay, please call
1-855-859-2056 (U.S.) or 1-404-537-3406 (international) and dial the
participant passcode 56363760. The webcast will be archived on www.gilead.com
for one year.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936